Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Eucrisa (crisaborole) and Dupixent (dupilumab) are both used to treat eczema, but they have some key differences. Eucrisa is a topical ointment that you apply to your skin, while Dupixent is an injectable medication. Eucrisa works by blocking the phosphodiesterase 4 (PDE4) enzyme to reduce inflammation and itching, and it's safe for children as young as 3 months. On the other hand, Dupixent is a monoclonal antibody that targets specific proteins to calm the immune system and is approved for children as young as 6 months. Both Dupixent and Eucrisa are only available as brand medications, but Dupixent is an injection, making it potentially more expensive. Additionally, Dupixent treats a wider range of conditions, including asthma and sinus congestion with nasal polyps, and is administered every other week or monthly, compared to Eucrisa's twice-daily application. Common side effects of Eucrisa include application site pain, while Dupixent can cause injection site reactions and eye inflammation.
Eucrisa (crisaborole)
Dupixent (dupilumab)
Eucrisa (crisaborole)
Dupixent (dupilumab)
Summary of Eucrisa vs. Dupixent
Summary for PDE4 inhibitor
Prescription only
Eucrisa (crisaborole) is an ointment that's used to treat eczema for people 3 months and older. The medication is a phosphodiesterase 4 (PDE4) inhibitor that works to help reduce skin inflammation and itching from eczema. The ointment is usually applied to the affected area(s) of skin twice a day. The most common side effect is burning or stinging on the skin where you apply the medication.
Summary for Interleukin antagonist
Prescription only
Dupixent (dupilumab) is an injection that helps treat certain inflammatory conditions. This includes eczema, asthma, and chronic obstructive pulmonary disease (COPD), among others. It's a biologic medication known as an interleukin antagonist that lowers inflammation. Dupixent (dupilumab) comes as prefilled pens and prefilled syringes. It's injected under the skin of the belly or thighs (or in the back of the upper arm with someone's help). The dosing schedule depends on the condition you have, your age, and your weight. It's injected either every week, every 2 weeks, or every 4 weeks. Side effects include injection site reactions and eye problems.